Develops drugs for gastrointestinal diseases.
Jun 2026Revenue $240M/yrExpenses $280M/yr
No trendCash runway ≈ 4.9 years from Jun 2026
Figures by year
When will Phathom Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $240M and expenses $280M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $175M | $335M | −$160M |
| Dec 2024 | $55.3M | $333M | −$277M |
| Dec 2023 | $682K | $168M | −$167M |
| Dec 2022 | $0.00 | $172M | −$172M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.